The purified human monocytes of a responding donor preincubated with heat-inactivated serum T1264 or T1295 derived from pregnant women for 30 min at 37 degrees C expressed allogeneic suppressive effects on the proliferative response of the lymphocytes from the same donor in the allogeneic mixed lymphocyte reaction (MLR). The pregnancy serum in our experiments was found not to contain any antibodies to DR and DQ antigens on monocytes of the responding donor. Accordingly, the suppressive effects mediated by monocytes were not based on the blocking of DR and DQ antigens on monocytes of the responding donor by DR and DQ antibodies in the serum. These highly reproducible allogeneic suppressive effects by monocytes of the responding donor were demonstrated in the MLR specific for DRw9-positive stimulating cells, whereas no inhibition was seen in the cultures with other stimulating cells of different DR phenotypes. Additionally, these suppressive effects appeared on the monocytes of a DR2-positive responding donor, but not on the monocytes of a DR2-negative responding donor. These suppressive effects were abolished when the absorbed pregnancy serum by monocytes of the DR2-positive responding donor was used. In this suppression phenomenon that we discovered, monocytes of the responding donor appear to act as regulatory cells on the proliferative response of the allogeneic MLR. This regulatory function of monocytes could be expressed through the [ 
Introduction
Humoral and cell-mediated immune responses are subject to regulatory control through a variety of suppressor mechanisms. In studies on mice, a subpopulation ofthymus-derived (T) lymphocytes that express Ly2 and 3 antigens (1), a substance released from macrophages (2), a membrane component of macrophages (3) , certain IgM antibodies (4) , and antiidiotypic antibodies (5) is known to suppress a variety of immune responses. Cortisonesensitive cells that adhere to glass wool suppress [3H] thymidine incorporation in stimulated cultures of rat spleen cells (6, 7) . Furthermore, in humans, the regulatory function ofT cell subsets (suppressor T cells) on the proliferative response in allogeneic mixed lymphocyte reaction (MLR)' has been confirmed (8, 9) .
In these studies, the suppressor T cells inhibited the response of individuals who shared HLA Dw specificity with responding cells.
There is considerable evidence that macrophages broadly inhibited the T cell proliferation to B + null cells in a dosedependent fashion throughout the time course ofthe autologous MLR (10) , although the nature of macrophages in responding cells remains controversial. Also in the allogeneic MLR, the lymphoproliferation was nonspecifically suppressed in the presence of high concentrations of mononuclear cells in which the suppressor cells might have been one of the monocyte series (I1).
Many reports (12) (13) (14) (15) (16) (17) (18) (19) (20) have already been published on the role of peripheral blood monocytes in the MLR. In these studies, stimulating or responding cell samples in which monocytes were enriched or depleted were used. Especially, Mann and Abelson (21) have demonstrated that monocytes present in the stimulating or responding cell population were necessary for lymphocyte proliferation in the MLR and that this proliferative response was inhibited by alloimmune sera, which reacted to the DR antigens on monocytes of the responding cell population.
Other studies (22, 23) have demonstrated that alloimmune sera markedly inhibited in vitro immune responses. Muchmore et al. (22) have suggested that monocytes treated with anti-DR antisera appeared to suppress the ability of antigen-pulsed monocytes to stimulate antigen-specific proliferation of T cells.
During the examination of pregnancy sera, we found that allogeneic suppressive effects in MLR were expressed by purified monocytes incubated with the sera for a fixed period of time and then washed completely. Sera T1264 and T1295 in these experiments were found not to contain any antibodies to DR and DQ antigens on responding cells. The suppressive effects of the sera were demonstrated only on MLR, in which the phenotypes of the stimulators were HLA-DRw9 positive, whereas these suppressive effects on MLR were not observed if the stimulators were DRw9 negative. Moreover, these suppressive effects appeared on monocytes of a DR2-positive responding donor, but not on monocytes of a DRw8-positive or a DRI-positive responding donor.
In this paper, the possible roles of monocytes and factors in pregnancy sera on allogeneic MLR will be discussed.
Methods
Blood samples were obtained from a panel of healthy persons known to be homozygous or heterozygous for HLA antigens.
Sera. Pregnancy sera T1264 and T1295 were examined after absorption with pooled platelets. Serum T1264 contained antibodies to DR7 and DRw9, and serum T1295 contained antibodies to DR4 and DRw9.
Preparation ofcells. Mononuclear cells were isolated from fresh venous blood by centrifugation with a Ficoll-Hypaque gradient. These cells were resuspended in RPMI 1640 medium containing 10% pooled normal human AB serum (NHS) and were plated in a glass petri dish at 37°C In experiment 1, each preincubated monocyte preparation of responding donor M.N. was reconstituted with lymphocytes (nonadherent cells) from the same donor at the ratio 1:10. In experiment 2, each preincubated lymphocyte preparation was reconstituted with monocytes at the ratio 10:1. In experiment 3, each preincubated T cell preparation was reconstituted with monocytes and B cells at the ratio 10:1:
lymphocytes (L), and T cells (T) were preincubated with NHS* and serum T1295t, respectively. § Significant suppression, P < 0.001.
clonal antibody OKM 1. The monocyte preparations used were >95% pure. The nonadherent cells were separated into enriched T cells and B cells using a nylon wool method described by Danilovs et al. (24) with some modifications. More than 95% of the separated T cells were killed by monoclonal antibody OKT3 in a complement-dependent cytotoxicity assay. Treatment ofmonocytes. Monocytes separated by the above-described procedure were preincubated for 30 min at 37°C with a heat-inactivated pregnancy serum and pooled NHS (control), at the ratio of400 Ml serum to 1 X 106 monocytes, and then washed three times with RPMI 1640 medium.
Mixed lymphocyte cultures. RPMI 1640 medium supplemented with pooled NHS at 20% was used throughout as the culture medium. The Fractionation ofpregnancy serum. Pregnancy serum T1295 was fractionated using high performance liquid chromatography. An aliquot of fivefold-diluted pregnancy serum T1295 (5 ml) was applied to anion exchange column Mono Q (Pharmacia Fine Chemicals, Piscataway, NJ). After the serum application, the column was washed with three bed Tables I and II. In Table I , the monocytes were preincubated with serum T1264 and in Table II Table IV (with serum T1264), the suppression of MLR was not observed when DRw8-positive responding cells were co-cultured with DRw9-positive stimulating cells as well as with other stimulating cells with a different DR phenotype. In the same way, the monocytes of responding donor A.I., who had HLA A24,24, B7,-, C7,-, DRll, and DQwl, 1 (homozygote, confirmed by a family study), were incubated with serum T1264 or T1295. As with the monocytes of the DRw8-positive responding donor, suppression of MLR was not observed. Absorption experiments on pregnancy serum with monocytes or B cells. We next tested whether the suppressive effects could be expressed when the monocytes of a responding donor, which were incubated with the absorbed pregnancy serum by the same monocytes, were used in the allogeneic MLR. The monocytes of a responding donor with DR2 homozygote were incubated with pregnancy serum T 1264 that had previously been absorbed by the monocytes from the same responding donor. Then the preincubated monocytes were reconstituted with lymphocytes from the same donor. Table V shows that these suppressive effects were abolished when the pregnancy serum was absorbed with monocytes from the responding donor.
The following absorption experiment was also carried out to exclude the possibility that the contaminated anti-DRw9 antibody in the pregnancy serum had an effect on the suppression ofMLR. Pregnancy serum T1264 was absorbed with B cell lines (with DR4 and Drw9 specificity), and then the removal of antiDRw9 antibody from the serum was assessed by the standard lymphocyte cytotoxicity test. Thus, pregnancy serum was provided for the preincubation with monocytes of the responding donor. The results are presented in Table VI and show that the suppressive effect on the proliferative response of lymphocytes in the MLR was not affected by absorption of anti-DRw9 antibody in the pregnancy serum.
MLR suppressive effects infractions ofserum T1295 by anion exchange chromatography. Serum T1295 was fractionated on an anion exchange column. Molecules of the serum bound to the column were eluted using a linear 0.0-0.5 M NaCl gradient and separated into six fractions. Serum protein components in each fraction were examined by immunodiffusion. In addition, analysis of the first fraction by SDS-polyacrylamide gel electrophoresis revealed a single band as IgG molecules (data not 1  2X  4X  8X  1  2X  4X  8X  1  2X  4X  8X  I  2X  4X  8X  1  2X  4X  8X   Monocytes  1 
Each serum was serially diluted to 1:8. Percent of cytotoxicity score: 8 > 70; 6 > 40; 4 > 20; 2 > 10; and 1 < 10 dead cells.
shown). A suppressive activity was found to have been eluted in the first fraction, which corresponds closely to IgG molecules, as shown in Table VII . In contrast, subsequent IgG-negative fractions had no effect on MLR responsiveness. Analysis ofa factor in pregnancy sera T1264 and T1295 by a binding test. As shown in Fig. 1 (left) , when the monocytes of donor M.N. (DR2 and DQwl homozygote) were incubated with serum T1264 or T1295, human Ig molecules were observed, using fluorescein-conjugated goat anti-human Ig, to bind on the surface ofthe monocytes. In contrast, when the monocytes from donor S.G. (DRw8 and DQwI heterozygote) were incubated with serum T1264 or T1295, no binding of human Ig was observed on the monocytes (Fig. 1, right) .
Reactivity ofantibodies in serum T1264 and T1295 against monocytes. The following study was performed to examine whether these antibodies reacted with DR, DQ, and DP determinants on monocytes from donor M.N. Table VIII shows the results of a monocyte cytotoxicity test. Neither serum T1264 nor T 1295 gave positive cytotoxic reactions on the monocytes. However, some recently accumulated data indicated that anti-DQ antibody could not be detected on monocytes by a serological microcytotoxicity test. Therefore, a blocking study on monocytes was performed using a fluorescein-conjugated monoclonal monomorphic antibody, Leu 10, which had been shown to react selectively with DQ antigen. As shown in Fig. 2 (left) , anti-DQw I alloantiserum (serum T847) had blocking effects on the binding activity of Leu 10. In contrast, sera T1264 and T1295 had no blocking effect on the binding of Leu 10 (Fig. 2, right) .
A blocking experiment using a monoclonal anti-DP monomorphic antibody (anti-FA) was also performed (Fig. 3) . Monocytes pretreated with T1264 or T1295 were found to have re- These results suggested that sera T 1264 and T1295 contain antibodies to the DP determinants on monocytes of donor M.N., but not to the DR determinants and the DQ determinants.
Evidence that these suppressive effects were dependent on the number ofmonocytes used. The MLR responses were examined with various numbers ofpreincubated monocytes ofresponding cells (Fig. 4) . MLR responses were more suppressed in cultures in which a greater number of preincubated monocytes with serum T1295 in responding cells from donor M.N. were used. No suppressive effects could be seen in the experiment using an equal number of preincubated monocytes with NHS to lymphocytes in responding cells.
Discussion
Stimulation in MLR represents a response to gene products of the HLA-D region in the major histocompatibility complex (25) . The D region appears to encode a number ofantigens including the DR, DQ, and DP antigens.
Many previous investigators have reported that alloimmune sera have inhibitory effects on the proliferative response in allogeneic MLR. They have thought that the inhibitory effects were based on the blocking of DR antigens on stimulating cells or responding cells by DR antibodies in the sera.
Pregnancy sera were examined for their possible suppressive effects that were mediated by monocytes on allogeneic MLR. It has been observed that the purified monocytes of responding donor M.N. preincubated with heat-inactivated pregnancy serum T1264 or T1295 for a fixed period of time expressed allogeneic suppressive effects on the proliferative response of the lympho- Although the immunosupp-essive effects in the human allogeneic MLR may be a complex ofdifferent immunosuppressive mechanisms, the present study found that factors other than suppressor cells may also play an important role in the suppression ofthe allogeneic MLR. Based on studies ofthe mouse model, Nagarkatti et al. (5) have suggested that an antiidiotypic antibody induced by transfusion can block the antigen-specific receptor on the T cells and cause suppression of the recipient's response against a donor's alloantigens in MLR. In contrast, our study demonstrates another suppression mechanism of the allogeneic MLR based on the reaction ofantibodies in the pregnancy serum with specific molecules on monocytes. In the suppression mechanism we propose, monocytes react with antibodies in the pregnancy serum through specific molecules on monocytes that are distinct from DR or DQ determinants on monocytes of the responding donor. Consequently, the monocytes that were reacted with the antibodies provide a regulatory signal for T cell proliferation. As a result, the T cell proliferation in MLR for certain types ofstimulators was suppressed. Further studies are in progress to examine whether these suppressions were expressed by the reaction ofmonocytes with anti-DP antibodies or with other antibodies (such as antiidiotypic antibody) in the pregnancy sera.
It is an immunological paradox to see a suppression of allogeneic MLR respond to DRw9-positive stimulating cells along with anti-DRw9 antibody in the pregnancy sera. This suppression might be expressed to balance the maternal immune response to fetal antigens that provide for fetal well-being.
Although more studies are necessary before a definitive conclusion regarding the role of monocytes and antibodies in preg-nancy sera can be reached, it may be that a suppression mechanism mediated by monocytes and antibodies (distinct from anti-DR antibody and anti-DQ antibody) in the pregnancy sera also plays an important role, along with a variety of other suppression phenomena.
